MedPage Today on MSN1d
Mixed Results for Therapeutic Candidates for Platinum-Resistant Ovarian CancerPromising therapies for platinum-resistant ovarian cancer produced mixed results in separate trials. The AKT inhibitor ...
Striking study results last year indicated a new type of medicine may improve on Merck’s immunotherapy, spurring a wave of ...
Additionally, the prognosis of macular edema may help clinicians evaluate renal function, investigators reported ...
Stockhead on MSN21h
Health Check: Awaiting key announcements, these biotechs could use some Irish luckOn St Patrick's Day, investors hope for the luck of the Irish ahead of Opthea's key phase III trial update ... Read More The ...
Anti-VEGF therapy improves outcomes in retinal diseases by targeting neovascularization and macular edema, crucial in conditions like AMD and diabetic retinopathy. Optical coherence tomography is ...
DUBLIN--(BUSINESS WIRE)--The "PD-1 x VEGF and PD-L1 x VEGF Bispecific Antibodies: A Business, Pipeline And Competitor Analysis From An Industry Perspective" report has been added to ...
Physicians’ Education Resource (PER ®) is excited to announce the launch of Retina Resource, a comprehensive source of cutting-edge education and information on the latest innovations in anti-VEGF ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback